Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1
Roger Belizaire, Sebastian Koochaki, Namrata D. Udeshi, et al.
Blood (2021) Vol. 137, Iss. 16, pp. 2209-2220
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Targeting Akt in cancer for precision therapy
Hui Hua, Hongying Zhang, Jingzhu Chen, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 164
Endocytosis in cancer and cancer therapy
Blerida Banushi, Shannon R. Joseph, Benedict Lum, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 450-473
Closed Access | Times Cited: 97
Role of CBL Mutations in Cancer and Non-Malignant Phenotype
Davide Leardini, Daria Messelodi, Edoardo Muratore, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 839-839
Open Access | Times Cited: 29
CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma
Xiyue Xu, Yidan Zhang, Yaxiao Lu, et al.
Cancer Research (2024) Vol. 84, Iss. 13, pp. 2123-2140
Closed Access | Times Cited: 6
Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma
Sheng Wu, Xiangkang Lv, Yilin Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 27
Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks
Hongjie Guo, Chen Zhou, Mingming Zheng, et al.
Pharmacological Research (2024) Vol. 201, pp. 107084-107084
Open Access | Times Cited: 4
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
Erika Morsia, Elena Torre, Antonella Poloni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4573-4573
Open Access | Times Cited: 17
Echinacoside regulates PI3K/AKT/HIF-1α/VEGF cross signaling axis in proliferation and apoptosis of breast cancer
Hongyi Liang, Guoliang Yin, Guangxi Shi, et al.
Analytical Biochemistry (2023) Vol. 684, pp. 115360-115360
Closed Access | Times Cited: 10
Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins
Clifford Liongue, Alister C. Ward
Cancers (2024) Vol. 16, Iss. 2, pp. 313-313
Open Access | Times Cited: 3
Analysis and identification of potential biomarkers for dysfunctional uterine bleeding
Allan N. Zhang, Yuanji Liang, Yuanguang Meng, et al.
Journal of Reproductive Immunology (2025) Vol. 168, pp. 104427-104427
Closed Access
SOHO State of the Art Updates and Next Questions | Atypical chronic myeloid leukemia: pathogenesis, diagnostic challenges and therapeutic strategies
Alessandro Nanni Costa, Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
SOHO State of the Art Updates and Next Questions | Atypical Chronic Myeloid Leukemia: Pathogenesis, Diagnostic Challenges, and Therapeutic Strategies
Alessandro Nanni Costa, Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy
Di Xiao, Xin Hu, Mei Peng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 16
The interactions of CAP and LYN with the insulin signaling transducer CBL play an important role in polycystic ovary syndrome
Hao-Ran Shen, Xiao Xu, Zhongpeng Fu, et al.
Metabolism (2022) Vol. 131, pp. 155164-155164
Open Access | Times Cited: 15
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation
Jonathan Bohlen, Ivan Bagarić, Taja Vatovec, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Closed Access | Times Cited: 2
Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia
Claudia Fiñana, Noel Gómez-Molina, Sandra Alonso-Moreno, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1335-1335
Open Access | Times Cited: 11
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia
Aline Renneville, Mrinal M. Patnaik, Onyee Chan, et al.
Leukemia (2021) Vol. 35, Iss. 10, pp. 2739-2751
Closed Access | Times Cited: 14
Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors
Haiyun Wang, Ye Liu, Ling Deng, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage Lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway
XueFeng Feng, Lin Yang, Xiaojun Liu, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 1
scPharm: Identifying Pharmacological Subpopulations of Single Cells for Precision Medicine in Cancers
Peng Tian, Jie Zheng, Keying Qiao, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
TRPV1 Is a Potential Tumor Suppressor for Its Negative Association with Tumor Proliferation and Positive Association with Antitumor Immune Responses in Pan-Cancer
Rongfang Nie, Qian Liu, Xiaosheng Wang
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 7
LncRNA AL645608.3 mediates malignant progression of acute myeloid leukemia
Jin-Hua Yan
American Journal of Translational Research (2024) Vol. 16, Iss. 1, pp. 342-355
Open Access | Times Cited: 1
Association between CBL gene polymorphism and susceptibility of microscopic polyangiitis in a Chinese population: A case-control analysis
Liu Liu, Yan Zhu, Jingjing Lan, et al.
Cytokine (2024) Vol. 179, pp. 156596-156596
Closed Access | Times Cited: 1
Sorafenib regulates c-CBL gene-mediated chemoresistance in acute myeloid leukemia cells
Sun Qixin, Bingyi Wu, Fan‐Yi Meng, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Xudong Li, Wei Li, Yanli Zhang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101150-101150
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top